Novateor Research Laboratories Ltd Financials
Company Logo

Novateor Research Laboratories Ltd Financial Statement

Novateor Research Laboratories Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Mar 2020
Revenue0.39
Operating Expense0.33
Net Profit-0.02
Net Profit Margin-5.13
Earning Per Share-0.04
EBIDTA0.03
Effective Tax RateTBA
Invest in Novateor Research Laboratories Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions

Novateor Research Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual1.21
Operating Expenses Annual1.54
Operating Profit Annual0.16
Interest Annual0.03
Depreciation0.08
Net Profit Annual0.03
Tax Annual0.02

Novateor Research Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning0.22
Cash Flow from Operations-0.98
Cash Flow from Investing-0.25
Cash Flow from Financing1.10
Cash Flow at the End0.09

Novateor Research Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)13.22
PBIT Margin (%)6.61
PBT Margin (%)-214.05
Net PROFIT Margin (%)2.48
Return On Networth / Equity (%)0.37
Return On Networth /Employed (%)0.89
Return On Assets (%)0.32
Total Debt / Equity (X)0.12
Asset Turnover Ratio (%)0.13

Novateor Research Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual2.43
Total Current Assets Annual7.52
Non Current Assets Annual2.94
Total Shareholders Funds Annual8.76
Total Assets Annual10.46

Novateor Research Laboratories Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Nov 14, 2024, Novateor Research Laboratories Ltd has a market capitalization of - Cr. Value Research classifies it as a Micro-Cap company.
Yes, Novateor Research Laboratories Ltd is debt-free with a debt-to-equity ratio of 0.13.
In FY 2023 , Novateor Research Laboratories Ltd recorded a total revenue of approximately 1.21 Cr marking a significant milestone in the company's financial performance.
Novateor Research Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -100.0% and 0.2% annually, respectively..
Novateor Research Laboratories Ltd's current PE ratio is undefined.
Novateor Research Laboratories Ltd's ROCE averaged 1.4% from the FY ending March 2022 to 2024, with a median of 0.8%. It peaked at 2.6% in March 2022, reflecting strong capital efficiency over the period..
Novateor Research Laboratories Ltd's latest EBIT is Rs. 0.08 Cr, surpassing the average EBIT of Rs. -0.04 Cr over the 5 years..